Real-World Study of PADN for the Treatment of PAH

Recruiting now

Conditions studied: Pulmonary Hypertension, Hypertension, Pulmonary Arterial

In brief

Real-World Study of PADN for the Treatment of PAH

Key facts

Study ID

NCT07039604

Run by

Pulnovo Medical (Wuxi) Co., Ltd.

People needed

200

Starts

2025-03-19

Expected to finish

2028-12-30

Last updated by the study team

2025-06-26

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosed with PAH and received PADN procedure since March 2024.
• No contraindications to procedure.
• Able to provide informed consent and authorize use of health/research data.
• Compliant with treatment and follow-up requirements.

You may not qualify if…

• None specified.

Where it is running

• The First Affiliated Hospital with Nanjing Medical University — Nanjing, Jiangsu, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.